Last reviewed · How we verify
NCT06269757
Exercise Program for ITB Syndrome
NA trial testing Individualized Exercise Program in Iliotibial Band Syndrome in 100 participants. Not yet recruiting.
1 January 2026
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 August 2025 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 April 2026 |
Drugs / interventions tested
- Individualized Exercise Program
- Standard Physical Therapy
Conditions studied
- Iliotibial Band Syndrome — all drugs for Iliotibial Band Syndrome →
Sponsor
NYU Langone Health — full company profile →
Who can join
Adults 18 to 65, any sex, with Iliotibial Band Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with diagnosed iliotibial band (ITB) syndrome indicated for non-operative management will be randomized to individualized exercise program or standard physical therapy over the course of 3 months to determine any possible difference in clinical outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06269757
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Individualized Exercise Program
Trials testing the same drug.
- NCT01504789 — Part II: Exercise in Hispanic Breast Cancer Survivors · NA · active not recruiting
Other recruiting trials for Iliotibial Band Syndrome
Currently open trials in the same condition.
- NCT06867159 — Autogenic Inhibition Versus Reciprocal Inhibition Muscle Energy Techniques in Iliotibial Band Syndrome · NA · recruiting
- NCT06131658 — Effects of Functional Motor Control on Pain, Flexibility, Lower Extremity Function With ITBS · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06269757 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 30 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06269757.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing